TearLab Corporation Company Profile (NASDAQ:TEAR)

About TearLab Corporation (NASDAQ:TEAR)

TearLab Corporation logoTearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Glasses, Spectacles & Contact lenses
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TEAR
  • CUSIP: N/A
  • Web: www.tearlab.com
Capitalization:
  • Market Cap: $7.46 million
  • Outstanding Shares: 5,742,000
Average Prices:
  • 50 Day Moving Avg: $1.41
  • 200 Day Moving Avg: $1.86
  • 52 Week Range: $1.20 - $7.50
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.64
  • P/E Growth: -0.02
Sales & Book Value:
  • Annual Revenue: $28.06 million
  • Price / Sales: 0.27
  • Book Value: ($2.35) per share
  • Price / Book: -0.55
Profitability:
  • EBITDA: ($9,780,000.00)
  • Net Margins: -59.29%
  • Return on Assets: -66.38%
Debt:
  • Debt-to-Equity Ratio: -2.03%
  • Current Ratio: 2.60%
  • Quick Ratio: 2.14%
Misc:
  • Average Volume: 688,440 shs.
  • Beta: 2.74
  • Short Ratio: 0.56
 

Frequently Asked Questions for TearLab Corporation (NASDAQ:TEAR)

What is TearLab Corporation's stock symbol?

TearLab Corporation trades on the NASDAQ under the ticker symbol "TEAR."

When did TearLab Corporation's stock split? How did TearLab Corporation's stock split work?

TearLab Corporation's stock reverse split on the morning of Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of TearLab Corporation stock prior to the reverse split would have 10 shares after the split.

How were TearLab Corporation's earnings last quarter?

TearLab Corporation (NASDAQ:TEAR) released its quarterly earnings data on Monday, August, 14th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.75) by $0.07. The company had revenue of $7 million for the quarter, compared to analyst estimates of $6.86 million. The firm's quarterly revenue was up 1.4% on a year-over-year basis. During the same period last year, the firm earned ($0.08) EPS. View TearLab Corporation's Earnings History.

When will TearLab Corporation make its next earnings announcement?

TearLab Corporation is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for TearLab Corporation.

Where is TearLab Corporation's stock going? Where will TearLab Corporation's stock price be in 2017?

4 brokerages have issued 12-month target prices for TearLab Corporation's stock. Their predictions range from $4.00 to $9.00. On average, they expect TearLab Corporation's stock price to reach $5.75 in the next twelve months. View Analyst Ratings for TearLab Corporation.

Who are some of TearLab Corporation's key competitors?

Who are TearLab Corporation's key executives?

TearLab Corporation's management team includes the folowing people:

  • Elias Vamvakas, Chairman of the Board
  • Joseph Jensen, President, Chief Executive Officer, Chief Operating Officer, Director
  • Wes Brazell, Chief Financial Officer
  • Raymond Kong, Vice President - Sales
  • Venkiteshwar Manoj, Vice President of Medical Affairs
  • Paul Smith, Vice President - International Markets
  • Duane Morrison, Vice President - Business Development
  • Anthony E. Altig, Independent Director
  • Thomas N. Davidson Jr., Independent Director
  • Adrienne L. Graves Ph.D., Independent Director

How do I buy TearLab Corporation stock?

Shares of TearLab Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is TearLab Corporation's stock price today?

One share of TearLab Corporation stock can currently be purchased for approximately $1.30.


MarketBeat Community Rating for TearLab Corporation (NASDAQ TEAR)
Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  217 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  320
MarketBeat's community ratings are surveys of what our community members think about TearLab Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for TearLab Corporation (NASDAQ:TEAR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.75 (342.31% upside)
Consensus Price Target History for TearLab Corporation (NASDAQ:TEAR)
Price Target History for TearLab Corporation (NASDAQ:TEAR)
Analysts' Ratings History for TearLab Corporation (NASDAQ:TEAR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/15/2017HC WainwrightReiterated RatingBuy$4.00HighView Rating Details
5/16/2017Rodman & RenshawLower Price TargetBuy -> Buy$12.00 -> $4.00MediumView Rating Details
3/11/2017Craig HallumSet Price TargetBuy$6.00HighView Rating Details
3/11/2017Feltl & Co.DowngradeStrong-Buy -> Buy$9.00HighView Rating Details
8/4/2016Roth CapitalDowngradeBuy -> NeutralN/AView Rating Details
3/9/2016Canaccord GenuityReiterated RatingBuyN/AView Rating Details
(Data available from 10/20/2015 forward)

Earnings

Earnings History for TearLab Corporation (NASDAQ:TEAR)
Earnings by Quarter for TearLab Corporation (NASDAQ:TEAR)
Earnings History by Quarter for TearLab Corporation (NASDAQ TEAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017        
8/14/2017Q2 2017($0.75)($0.68)$6.86 million$7.00 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.75)($0.82)$7.02 million$6.70 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.90)($0.81)$7.71 million$7.12 millionViewListenView Earnings Details
11/7/2016Q316($0.08)($0.07)$7.13 million$20.90 millionViewListenView Earnings Details
8/3/2016Q2($0.08)($0.08)$6.95 million$6.90 millionViewN/AView Earnings Details
5/4/2016Q1($0.23)($0.21)$6.53 million$6.80 millionViewN/AView Earnings Details
3/8/2016Q4($0.25)($0.26)$6.83 million$6.80 millionViewN/AView Earnings Details
11/5/2015Q315($0.24)($0.24)$6.40 million$6.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.25)($0.24)$5.72 million$6.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.21)($0.25)$5.40 million$5.40 millionViewN/AView Earnings Details
3/12/2015Q414($0.17)($0.21)$5.50 million$5.30 millionViewN/AView Earnings Details
11/5/2014Q214($0.17)($0.17)$5.50 million$5.20 millionViewN/AView Earnings Details
8/7/2014Q114($0.16)($0.17)$5.12 million$9.20 millionViewN/AView Earnings Details
5/8/2014Q1($0.14)($0.17)$4.76 million$4.21 millionViewN/AView Earnings Details
3/13/2014Q413($0.13)($0.13)$4.49 million$4.40 millionViewN/AView Earnings Details
11/12/2013Q3($0.14)($0.13)$3.80 million$4.20 millionViewListenView Earnings Details
5/13/2013Q1 2013($0.12)($0.30)$2.18 million$2.47 millionViewN/AView Earnings Details
11/13/2012Q312($0.11)($0.10)$1.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for TearLab Corporation (NASDAQ:TEAR)
2017 EPS Consensus Estimate: ($1.42)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.71)($0.05)($0.38)
Q2 20172($0.69)($0.06)($0.38)
Q3 20172($0.62)($0.05)($0.34)
Q4 20172($0.60)($0.05)($0.33)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for TearLab Corporation (NASDAQ:TEAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for TearLab Corporation (NASDAQ:TEAR)
Insider Ownership Percentage: 12.00%
Institutional Ownership Percentage: 19.90%
Insider Trades by Quarter for TearLab Corporation (NASDAQ:TEAR)
Institutional Ownership by Quarter for TearLab Corporation (NASDAQ:TEAR)
Insider Trades by Quarter for TearLab Corporation (NASDAQ:TEAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/30/2017Awm Investment Company, Inc.Major ShareholderSell327,674$3.20$1,048,556.80View SEC Filing  
5/31/2016Brock WrightDirectorBuy59,686$0.78$46,555.08View SEC Filing  
5/26/2016Brock WrightDirectorBuy130,314$0.76$99,038.64View SEC Filing  
12/4/2014Elias VamvakasCEOBuy50,000$2.24$112,000.00View SEC Filing  
11/18/2014Elias VamvakasCEOBuy31,187$2.55$79,526.85View SEC Filing  
11/17/2014Elias VamvakasCEOBuy18,813$2.55$47,973.15View SEC Filing  
11/11/2014Elias VamvakasCEOBuy150,000$2.49$373,500.00View SEC Filing  
11/10/2014Elias VamvakasCEOBuy16,276$2.50$40,690.00View SEC Filing  
11/10/2014Joseph JensenCOOBuy43,375$2.31$100,196.25View SEC Filing  
8/20/2014Brock WrightDirectorBuy23,000$3.82$87,860.00View SEC Filing  
8/19/2014Brock WrightDirectorBuy11,354$3.83$43,485.82View SEC Filing  
8/12/2014Elias VamvakasCEOBuy70,000$3.43$240,100.00View SEC Filing  
6/30/2014Richard LindstromDirectorSell5,000$4.61$23,050.00View SEC Filing  
5/13/2014Elias VamvakasCEOBuy30,000$3.99$119,700.00View SEC Filing  
5/13/2014Joseph JensenCOOBuy48,693$4.11$200,128.23View SEC Filing  
4/1/2014Paul KarpeckiDirectorSell5,000$6.83$34,150.00View SEC Filing  
1/2/2014Paul KarpeckiDirectorSell5,000$9.47$47,350.00View SEC Filing  
12/31/2013Richard LindstromDirectorSell5,000$9.26$46,300.00View SEC Filing  
11/15/2013Richard LindstromDirectorSell5,000$8.95$44,750.00View SEC Filing  
10/11/2013Paul KarpeckiDirectorSell5,000$10.96$54,800.00View SEC Filing  
9/3/2013William DumencuCFOSell7,000$13.22$92,540.00View SEC Filing  
8/1/2013William DumencuCFOSell7,000$14.39$100,730.00View SEC Filing  
7/1/2013Paul KarpeckiDirectorSell5,000$10.62$53,100.00View SEC Filing  
7/1/2013William DumencuCFOSell7,000$10.61$74,270.00View SEC Filing  
6/3/2013William DumencuCFOSell7,000$11.35$79,450.00View SEC Filing  
4/2/2013Tom Jr. DavidsonDirectorBuy1,500$6.63$9,945.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for TearLab Corporation (NASDAQ:TEAR)
Latest Headlines for TearLab Corporation (NASDAQ:TEAR)
Source:
DateHeadline
streetinsider.com logoTearLab (TEAR) Offers Update on U.S. Regulatory Strategy for TearLab Discovery System
www.streetinsider.com - October 18 at 9:21 AM
baystreet.ca logoTearLab Corporation
www.baystreet.ca - October 18 at 9:21 AM
reuters.com logoBRIEF-Tearlab corporation provides update on U.S. regulatory strategy for Tearlab Discovery™ System
www.reuters.com - October 18 at 9:21 AM
reuters.com logoBRIEF-Tearlab - ‍entered amendment to its term loan agreement, dated as of March 2015
www.reuters.com - October 17 at 7:57 AM
finance.yahoo.com logoIs TearLab Corporation (TEAR) Cheap And High Growth?
finance.yahoo.com - October 17 at 7:57 AM
finance.yahoo.com logoTearLab Corporation Provides Update on U.S. Regulatory Strategy for TearLab Discovery™ System
finance.yahoo.com - October 17 at 7:57 AM
americanbankingnews.com logoTearLab Corporation (TEAR) Expected to Post Earnings of -$0.69 Per Share
www.americanbankingnews.com - October 14 at 8:20 PM
finance.yahoo.com logoStep Beyond Bargain Hunting: 5 Stocks With Rising P/E
finance.yahoo.com - October 2 at 8:58 AM
bizjournals.com logoMedical Research Stock Performance Review -- OpGen, TearLab, TrovaGene, and PRA Health Sciences
www.bizjournals.com - September 29 at 9:38 AM
seekingalpha.com logoTearLab (TEAR) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 14 at 11:05 AM
globenewswire.com logoTearLab to Present at the 19th Annual Rodman and Renshaw Global Investment Conference - GlobeNewswire (press release)
globenewswire.com - September 13 at 10:00 AM
finance.yahoo.com logoTearLab to Present at the 19th Annual Rodman and Renshaw Global Investment Conference
finance.yahoo.com - September 11 at 7:32 AM
americanbankingnews.com logo-$0.70 EPS Expected for TearLab Corporation (TEAR) This Quarter
www.americanbankingnews.com - September 7 at 10:46 AM
finance.yahoo.com logoETFs with exposure to TearLab Corp. : September 1, 2017
finance.yahoo.com - September 1 at 9:35 AM
finance.yahoo.com logoETFs with exposure to TearLab Corp. : September 1, 2017
finance.yahoo.com - September 1 at 9:35 AM
americanbankingnews.com logoTearLab Corporation (TEAR) Short Interest Down 25.4% in August
www.americanbankingnews.com - August 29 at 1:08 AM
finance.yahoo.com logoTearLab Corp. :TEAR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 9:17 AM
finance.yahoo.com logoEarnings Review and Free Research Report: Bruker’s Adjusted Diluted EPS Increased 15%
finance.yahoo.com - August 23 at 12:28 PM
streetinsider.com logoAfter-Hours Stock Movers 08/21: (RT) (PCRX) Higher; (TEAR) (NDSN) (FN) Lower (more...)
www.streetinsider.com - August 21 at 8:30 PM
reuters.com logoBRIEF-TearLab corp - files for offering of up to $15 million - SEC filing‍
www.reuters.com - August 21 at 8:30 PM
americanbankingnews.com logo-$0.70 Earnings Per Share Expected for TearLab Corporation (TEAR) This Quarter
www.americanbankingnews.com - August 19 at 8:26 PM
americanbankingnews.com logoHC Wainwright Analysts Give TearLab Corporation (TEAR) a $4.00 Price Target
www.americanbankingnews.com - August 15 at 6:40 PM
finance.yahoo.com logoInvestor Network: TearLab Corp. to Host Earnings Call
finance.yahoo.com - August 15 at 7:33 AM
finance.yahoo.com logoTearLab Corporation Reports Second Quarter and First Half 2017 Financial Results
finance.yahoo.com - August 15 at 7:33 AM
finance.yahoo.com logoTearLab reports 2Q loss
finance.yahoo.com - August 15 at 7:33 AM
finance.yahoo.com logoEdited Transcript of TEAR earnings conference call or presentation 14-Aug-17 8:30pm GMT
finance.yahoo.com - August 15 at 7:33 AM
americanbankingnews.com logoTearLab Corporation (TEAR) Posts Earnings Results, Beats Estimates By $0.07 EPS
www.americanbankingnews.com - August 14 at 6:06 PM
americanbankingnews.com logoTearLab Corporation (TEAR) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - August 7 at 9:56 AM
americanbankingnews.com logo$6.72 Million in Sales Expected for TearLab Corporation (TEAR) This Quarter
www.americanbankingnews.com - August 3 at 7:26 AM
feeds.benzinga.com logoTearLab Corporation to Release Second Quarter 2017 Financial Results on August 14, 2017
feeds.benzinga.com - August 2 at 5:20 PM
americanbankingnews.com logoComparing Cooper Companies, Inc. (The) (COO) and TearLab Corporation (TEAR)
www.americanbankingnews.com - July 24 at 10:18 PM
americanbankingnews.com logoTearLab Corporation (NASDAQ:TEAR) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - July 17 at 8:30 PM
americanbankingnews.com logoTearLab Corporation (TEAR) Expected to Announce Quarterly Sales of $6.72 Million
www.americanbankingnews.com - July 12 at 11:30 AM
americanbankingnews.com logo-$0.73 Earnings Per Share Expected for TearLab Corporation (TEAR) This Quarter
www.americanbankingnews.com - July 10 at 10:13 AM
americanbankingnews.com logoCooper Companies, Inc. (The) (COO) and TearLab Corporation (TEAR) Critical Survey
www.americanbankingnews.com - July 6 at 8:28 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-Tesla, Diebold Nixdorf, DryShips
www.nasdaq.com - July 6 at 12:28 PM
reuters.com logoBRIEF-Tearlab Corp reports Q1 loss per share of $0.82
www.reuters.com - May 16 at 8:08 PM
streetinsider.com logoTearLab (TEAR) Reports Brazilian Regulatory Approval for Osmolarity System
www.streetinsider.com - May 14 at 11:39 AM
reuters.com logoBRIEF-TearLab osmolarity system receives Brazilian regulatory approval
www.reuters.com - May 13 at 1:39 AM
seekingalpha.com logoBiotech Forum Daily Digest: Gilead Facing Increasing Analyst Pressure, Spotlight On Epizyme
seekingalpha.com - March 13 at 8:53 AM
benzinga.com logoMid-Aternoon Market Update: Crude Oil Down 1.5%; Citi Trends ... - Benzinga
www.benzinga.com - March 11 at 6:20 AM
biz.yahoo.com logoTEARLAB CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 11 at 6:19 AM
seekingalpha.com logoTearLab's (TEAR) CEO Seph Jensen on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 1:07 AM
reuters.com logoBRIEF-Tearlab Corp Q4 loss per share $0.81
www.reuters.com - March 10 at 1:07 AM
seekingalpha.com logoTearLab beats by $0.01, misses on revenue
seekingalpha.com - March 9 at 8:07 PM
biz.yahoo.com logoQ4 2016 TearLab Corp Earnings Release - After Market Close
us.rd.yahoo.com - March 9 at 8:07 PM
us.rd.yahoo.com logoTearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results
us.rd.yahoo.com - March 9 at 8:07 PM
biz.yahoo.com logoTEARLAB CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
us.rd.yahoo.com - March 9 at 8:07 PM
globenewswire.com logoTearLab Announces CE Marking for Next-Generation System - GlobeNewswire (press release)
globenewswire.com - March 8 at 1:01 AM
reuters.com logoBRIEF-Tearlab's In-Vitro diagnostics testing platform got CE marking of device
www.reuters.com - March 6 at 7:26 PM

Social

Chart

TearLab Corporation (TEAR) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.